Skip to McMaster Navigation Skip to Site Navigation Skip to main content

Younger Canadians more likely to try recreational cannabis

Nearly 1 in 5 Canadians may try cannabis or increase consumption of the drug after legalization for recreational use.

By Tina Depko, Health Sciences July 31, 2019

Jason Busse is associate director of the Michael G. DeGroote Centre for Medicinal Cannabis Research at McMaster. Photo by Tina Depko.

Expert Featured In This Story

Jason Walter Busse
Jason Walter Busse

Professor

See Profile

Nearly 1 in 5 Canadians may try cannabis or increase consumption of the drug after legalization for recreational use, according to research from McMaster.

Those more likely to do so are younger in age, have used cannabis in the past three months, have a higher income, and self-report their mental health as poor or fair.

This conclusion comes from an analysis by McMaster researchers of the 2018 National Cannabis Survey conducted by Statistics Canada.

The results were published in Canadian Medical Association Journal (CMAJ) Open.

“We wanted to take a closer look at the survey data to identify trends on who is more likely to try or use more recreational cannabis,” said Jason Busse, senior author, associate professor in the Department of Anesthesia, and associate director of the Michael G. DeGroote Centre for Medicinal Cannabis Research at McMaster. “It is important to understand if legalization results in greater use of cannabis.”

Based on more than 17,000 respondents who provided complete data for the Statistics Canada survey, researchers used a weighted analysis to represent nearly 28 million Canadians aged 15 and older. The data used in the study was collected from February to September 2018, before legalization of recreational cannabis in Canada in October 2018.

An estimated 12 per cent of respondents indicated they intended to try cannabis, and six per cent intended to increase their cannabis use, following legalization.

Being more likely to try or increase cannabis use was associated with:

  • those younger in age, with those aged 15 to 24 being almost four times more likely to do so than those over age 65;
  • those who had used cannabis in the past three months were more than three times as likely versus those that had not;
  • those with a higher income of $80,000 or more were 1.5 times more likely compared to those earning less than $40,000;
  • and those reporting poor or fair mental health were twice as likely versus those reporting good to excellent mental health.

Busse said that while intention may not translate into behaviour, continued monitoring can help establish rates and patterns of recreational cannabis use among Canadians after legalization.

“Clinicians, public health officials and policy-makers should pay special attention to these higher risk populations to ensure informed decision making and responsible use,” he said.

Funding for the study came from the Social Sciences and Humanities Research Council (SSHRC), the Canadian Institutes of Health Research (CIHR), Statistics Canada and McMaster.

Read the paper here: http://cmajopen.ca/content/7/2/E399.full.

Gabriel Xiao sitting and smiling in the Baby Lab at McMaster, a bright room with toys in it.

Tiny scientists out in the world: Gabriel Xiao takes Baby Lab on the road 

Xiao’s software allows the McMaster Baby Lab to go out into the community using iPhone and iPads, making the lab accessible to families across Canada and the world.
A woman in a yellow sweater and white pants sits on a couch, holding her hands to her pelvis. Her face is not visible. The gesture makes it seem as if she is in some discomfort.

Early warning signs of chronic pelvic pain may appear in adolescence, McMaster study finds

Researchers found that many people who develop chronic pelvic pain may have been showing warning signs for years.
Two scientists examining cell cultures in a lab.

Prestigious journal Nature ranks McMaster among the top organizations worldwide for infectious disease research

The rankings are based on a five-year survey of infectious disease-related articles published in the world’s highest-impact scientific journals.